SCHEMBL7964092

SCHEMBL7964092

Cc1cc(Cl)ccc1C1CCN(CCCc2nnc3n2CCCCC3)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.53
HTR1A P08908 3/20 0.46
HTR2A P28223 3/20 0.46
CHRM2 P08172 1/20 0.46
ADRA2A P08913 1/20 0.46
ADRA2B P18089 1/20 0.46
ADRA1D P25100 1/20 0.46
HTR2C P28335 1/20 0.46
SLC6A4 P31645 1/20 0.46
ADRA1A P35348 1/20 0.46
DRD3 P35462 1/20 0.46
HTR2B P41595 1/20 0.46
GAA P10253 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
LMNA P02545 3/20 0.45
HPGD P15428 4/20 0.42
POLB P06746 1/20 0.42
HTT P42858 1/20 0.41
GFER P55789 1/20 0.41
TP53 P04637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7963490 0.89 LMNA (0.46) PKMHTR1AHTR2ACHRM2ADRA2A
SCHEMBL7964136 0.84 GAA (0.52) PKMHTR1AHTR2ACHRM2ADRA2A
SCHEMBL7957361 0.84 DRD2 (0.48) PKMHTR1AHTR2ACHRM2ADRA2A
Hydrochloric Acid SCHEMBL8570980 0.83 DRD2 (0.47) PKMHTR1AHTR2ACHRM2ADRA2A
SCHEMBL7959422 0.82 DRD2 (0.44) HTR1AHTR2ACHRM2ADRA2AADRA2B
SCHEMBL7961353 0.82 HTR1A (0.47) HTR1AHTR2ACHRM2ADRA2AADRA2B
SCHEMBL7957664 0.80 KDM4E (0.51) PKMHTR1AHTR2ACHRM2ADRA2A
SCHEMBL7960165 0.79 PKM (0.52) PKMHTR1AHTR2ACHRM2ADRA2A
SCHEMBL7959264 0.79 LMNA (0.53) PKMHTR1AHTR2ACHRM2ADRA2A
SCHEMBL7959113 0.79 L3MBTL1 (0.41) PKMHTR1AHTR2ACHRM2ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6187774-B1 N-PIPERAZINYLALKYLINDAZOLE DERIVATIVES; PSYCHOLOGICAL DISORDERS, SCHIZOPHRENIA; SIDE EFFECT REDUCTION YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2001-02-13 US disclosed
EP-0885883-A1 FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1998-12-23 EP disclosed